POLISCOPE
Back to feed
Part ofhealth

The Frame

What this does

This document outlines the current federal administrative focus and resource allocation regarding the treatment and management of Sickle Cell Disease.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Individuals with Sickle Cell Disease

The administration is implementing changes to Medicare and Medicaid access for gene therapy treatments and expanding community-based care resources.

Healthcare providers

Providers are subject to new data collection and coordination efforts managed by federal agencies to improve integrated care.

What changed

Last recorded activity August 30, 2024.

What's next

Next step not available in the current record.

Summary

President Biden has proclaimed September 2024 as National Sickle Cell Awareness Month to highlight the impact of Sickle Cell Disease (SCD) on Americans. The proclamation outlines federal efforts to improve treatment access, support clinical research, and address for those living with the condition.

Key Facts

  • Approximately 100,000 Americans live with Sickle Cell Disease.
  • The FDA approved the first gene therapies for SCD last year.
  • SCD disproportionately affects Black and Hispanic Americans.
  • Federal agencies are working to increase access to gene therapy treatments via Medicare and Medicaid.

Frequently Asked Questions

What is the purpose of National Sickle Cell Awareness Month?
The month is intended to recommit to finding a cure, supporting those with the disease, and addressing in communities.
What specific actions is the administration taking regarding SCD?
The administration is funding clinical trials, expanding access to gene therapies through Medicare and Medicaid, and improving data collection to better target resources.

Why It Matters

This document outlines the current federal administrative focus and resource allocation regarding the treatment and management of Sickle Cell Disease.

News Coverage

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Gene Therapy Access

The administration is explicitly linking Medicare and Medicaid policy to the accessibility of new gene therapy treatments for SCD.

Connected Entities

Sources

Open source document

www.federalregister.gov

Analysis Score

0–100
  • Significance40
    How much this matters to a regular citizen
  • Controversy5
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record